Get Slidell & St. Tammany News
Enter your email below to get local news in your inbox.

Florida is putting millions of dollars behind an intriguing possibility in cancer research. Could ivermectin, a medication that has been available for decades, help fight certain forms of cancer?
The state is taking that possibility seriously enough to fund further investigation.
Through the Florida Cancer Innovation Fund, Florida is supporting research into new cancer treatments, including the potential use of existing medications such as ivermectin.
Researchers are interested in whether ivermectin, traditionally prescribed to treat parasitic infections, could have applications beyond its original purpose, particularly when combined with other cancer therapies.
Some laboratory and animal studies have produced findings suggesting ivermectin may have anticancer properties, including effects on processes involved in tumor growth.
Another area of scientific discussion involves the possibility that certain cancers exhibit parasitic characteristics. Some researchers have explored whether cancer cells behave in ways comparable to parasites, drawing attention to their ability to consume resources, evade immune defenses, and survive at the expense of surrounding healthy tissue.
These theories have raised questions about whether medications originally developed to combat parasites could also have applications against certain cancers.
Florida has made $70 million available through its 2026–27 cancer research funding program, with drug repurposing among the areas of interest.
The appeal of repurposing existing medications is straightforward. Drugs already in use may offer researchers additional avenues to explore without starting entirely from scratch.
Whether ivermectin will ultimately prove beneficial for cancer patients remains a question for clinical research.
But Florida’s willingness to investigate that possibility highlights an interesting question. Could a medication developed decades ago hold answers researchers are only beginning to uncover?
Leave your comment below and let us know what you think!






What do you think? Join the conversation below.
Free. Straight to your inbox. Cancel anytime.
Join the conversation — create a free TRH News account to comment.